Early Relapse Approaches Using Monoclonal Antibodies | Phoenix AZ RT Nov 4, 2023

Early Relapse Approaches Using Monoclonal Antibodies | Phoenix AZ RT Nov 4, 2023
Roundtable Audience Q&A with Faculty | Phoenix AZ RT Nov 4, 2023
Decision-making for Relapsed/Refractory Myeloma | Phoenix AZ RT Nov 4, 2023
Understanding Your Protein Markers and MRD | Phoenix AZ RT Nov 4, 2023
Bispecific Antibodies: Looking into the Future | Phoenix AZ Nov 4, 2023
Using CAR T Earlier, Late and Future Advances | Phoenix AZ RT Nov 4, 2023
(Guest Lecture): November 2023 - Making the Most of Your Retirement Assets
Are there any bispecific antibodies that are FDA approved?